ITGAM and gastric neoplasm: In keeping with the scRNA-Seq results (Fig. S1F and S1G), we subsequently examined tiNeus (CD11b+Ly6G+) in mice bearing subcutaneous gastric tumors for 3, 10, and 20 days, and found that the proportion of tiNeus decreased rapidly with tumor progression, from 53.1% on day 3 to 6.02% on day 20 (Fig. S2H).